Prolific Parkinson’s Researcher Dr. Alberto J. Espay Joins Pharmather as Scientific Advisor TORONTO, Nov. 11, 2020 – Pharmather Inc., a wholly-owned subsidiary of Newscope Capital Corporation (“Pharmather” or the “Company”) (CSE: PHRM) and a specialty life...
Dr. Hauser to advise Pharmather on the clinical development of ketamine for Parkinson’s Disease TORONTO, Oct. 29, 2020 – Pharmather Inc., a wholly-owned subsidiary of Newscope Capital Corporation (“Pharmather” or the “Company”) (CSE: PHRM) and a specialty life...
MONTREAL, Oct. 19, 2020 – Dominion Water Reserves Corp. (“DWR” or the “Company”) (CSE:DWR), is pleased to announce that it has (i) appointed a new President and CEO, as well as a VP Marketing, (ii) closed a non-brokered private placement offering of units of DWR...
TORONTO, Oct. 15, 2020 – Pharmather Inc., a wholly-owned subsidiary of Newscope Capital Corporation (“Pharmather” or the “Company”) (CSE: PHRM) and a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is...
TORONTO, Oct. 13, 2020 – Pharmather Inc., a wholly-owned subsidiary of Newscope Capital Corporation (“Pharmather” or the “Company”) (CSE: PHRM) and a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is...
